COMMON STOCK AND NOTE PURCHASE AGREEMENTCommon Stock and Note Purchase Agreement • July 16th, 2015 • Opgen Inc • Services-medical laboratories • Delaware
THIS COMMON STOCK AND NOTE PURCHASE AGREEMENT, is made as of July 14, 2015 (this "Agreement"), by and among OpGen, Inc., a Delaware corporation (the "Company"), and Merck Global Health Innovation Fund, LLC, a Delaware limited liability company (the "Investor"). Certain capitalized terms used in this Agreement are set forth in Section 1.4.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 16th, 2015 • Opgen Inc • Services-medical laboratories • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of July 14, 2015, by and among OpGen, Inc., a Delaware corporation (the "Company"), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an "Investor."
AGREEMENT AND PLAN OF MERGER Dated as of July 14, 2015 among OPGEN, INC. VELOX ACQUISITION CORP. ADVANDX, INC. THE STOCKHOLDER PARTIES (as defined herein) and THE REPRESENTATIVES (as defined herein)Merger Agreement • July 16th, 2015 • Opgen Inc • Services-medical laboratories
This AGREEMENT AND PLAN OF MERGER, dated as of July 14, 2015 (this "Agreement"), is among OpGen, a Delaware corporation ("Parent"), Velox Acquisition Corp., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), AdvanDx, Inc., a Delaware corporation (the "Company"), and for purposes of Article VII only Merck Global Health Innovation Fund, LLC and SLS Invest AB, in their joint capacity as the Representatives of the Stockholder Parties hereunder and each as a Stockholder Party hereunder (individually a "Representative" and together the "Representatives"), and each of the other Persons listed on the signature pages hereto (collectively, the "Stockholder Parties"). Certain terms used in this Agreement are used as defined in Section 8.11.
